Millie is a new kind of maternity clinic. Built by moms and providers who’ve been there.
Seven Starling
Series A in 2024
Seven Starling is a digital clinic dedicated to addressing perinatal mental health issues, such as postpartum depression and anxiety. The clinic offers an evidence-based care model that integrates personalized therapy, peer support, and medication, with research indicating that 90% of patients experience improvement within three months. Additionally, Seven Starling provides an online platform featuring live, expert-led classes for expecting and new parents, covering topics related to childbirth and comprehensive prenatal and postpartum care. This approach fosters a supportive community that helps parents navigate the various stages of pregnancy and early child development.
Raydiant Oximetry
Series A in 2024
Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth. The company develops a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood. It develops and distributes a non-invasive technology that directly monitors a babies' oxygenation during pregnancy. This technology will lead to better patient care and greatly reduce the number of unnecessary cesarean sections. Founded in 2015 by Neil Ray, Raydiant Oximetry is headquartered in Mountain View, California.
Katana Pharmaceuticals
Grant in 2020
Katana Pharmaceuticals is a biotech company developing novel treatments for neonatal patient populations and rare pediatric disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.